ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,395
-99.5%
39,105
+332.4%
0.00%
Q3 2022$306,000
-91.8%
9,044
-95.0%
0.00%
-100.0%
Q3 2020$3,744,000
+0.2%
179,631
+14.2%
0.01%
-14.3%
Q2 2020$3,736,000
+634.0%
157,318
+455.9%
0.01%
+600.0%
Q1 2020$509,000
-58.6%
28,300
-45.3%
0.00%
-66.7%
Q4 2019$1,228,000
-2.2%
51,781
+44.5%
0.00%0.0%
Q1 2019$1,256,00035,8360.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders